Ceftriaxone and Silver drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftriaxone (ceftriaxone sodium) and Silver (colloidal silver). Common drug interactions include decreased appetite among females and toxic epidermal necrolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftriaxone and Silver. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Silver?

Silver has active ingredients of colloidal silver. eHealthMe is studying from 1,674 Silver users. Check the latest studies of Silver.

On Jul, 29, 2026

38 people who take Ceftriaxone and Silver together, and have interactions are studied.

Ceftriaxone and Silver drug interactions.

What are the common drug interactions of Ceftriaxone and Silver, by gender? *:

female:

Decreased appetite
Dysphagia (a condition in which swallowing is difficult or painful)
Nausea (feeling of having an urge to vomit)
Neuropathy peripheral (surface nerve damage)
Retching (strong involuntary effort to vomit)
Weight decreased
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Vomiting

male:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Drug hypersensitivity
Haemoglobin decreased
Hepatic failure (liver failure)
Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
Hypovolaemia (a decreased volume of circulating blood in the body)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Melaena (the passage of black, tarry stools)
Mycobacterium fortuitum infection (bacterial infection)
Pain

What are the common drug interactions of Ceftriaxone and Silver, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Vomiting

20-29:

Drug ineffective
Mycobacterium fortuitum infection (bacterial infection)

30-39:

n/a

40-49:

Encephalopathy (functioning of the brain is affected by some agent or condition)
Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematemesis (vomiting of blood)
Haemoglobin decreased
Hepatic failure (liver failure)
Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
Hypovolaemia (a decreased volume of circulating blood in the body)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Melaena (the passage of black, tarry stools)

50-59:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Drug hypersensitivity
Burkholderia test positive
Respiratory disorder (respiratory disease)
Sputum culture positive
Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

Chronic kidney disease
Decreased appetite
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Ill-Defined Disorder: 21 people, 55.26%
Erythema Multiforme (a type of hypersensitivity reaction): 20 people, 52.63%
Pneumonia: 19 people, 50.00%
Diabetes: 13 people, 34.21%
High Blood Pressure: 4 people, 10.53%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 7.89%
Pain: 3 people, 7.89%
Constipation: 3 people, 7.89%
Nausea (feeling of having an urge to vomit): 3 people, 7.89%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and Silver?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously